Your browser doesn't support javascript.
loading
The Breadth of the Neutralizing Antibody Response to Original SARS-CoV-2 Infection is Linked to the Presence of Long COVID Symptoms.
Buck, Amanda M; Deitchman, Amelia N; Takahashi, Saki; Lu, Scott; Goldberg, Sarah A; Hoh, Rebecca; Williams, Meghann C; Kerbleski, Marian; Deveau, Tyler-Marie; Munter, Sadie E; Lombardo, James; Wrin, Terri; Petropoulos, Christos J; Durstenfeld, Matthew S; Hsue, Priscilla Y; Kelly, J Daniel; Greenhouse, Bryan; Martin, Jeffrey N; Deeks, Steven G; Peluso, Michael J; Henrich, Timothy J.
Affiliation
  • Buck AM; Division of Experimental Medicine, University of California San Francisco, San Francisco, CA, United States.
  • Deitchman AN; Department of Clinical Pharmacy, University of California San Francisco, San Francisco, CA, United States.
  • Takahashi S; Division of HIV, ID and Global Medicine, University of California San Francisco, San Francisco, CA, United States.
  • Lu S; Department of Epidemiology and Biostatistics, University of California San Francisco, San Francisco, CA, United States.
  • Goldberg SA; Department of Epidemiology and Biostatistics, University of California San Francisco, San Francisco, CA, United States.
  • Hoh R; Division of HIV, ID and Global Medicine, University of California San Francisco, San Francisco, CA, United States.
  • Williams MC; Division of HIV, ID and Global Medicine, University of California San Francisco, San Francisco, CA, United States.
  • Kerbleski M; Division of HIV, ID and Global Medicine, University of California San Francisco, San Francisco, CA, United States.
  • Deveau TM; Division of Experimental Medicine, University of California San Francisco, San Francisco, CA, United States.
  • Munter SE; Division of Experimental Medicine, University of California San Francisco, San Francisco, CA, United States.
  • Lombardo J; Division of HIV, ID and Global Medicine, University of California San Francisco, San Francisco, CA, United States.
  • Wrin T; Monogram Biosciences, South San Francisco, CA, United States.
  • Petropoulos CJ; Monogram Biosciences, South San Francisco, CA, United States.
  • Durstenfeld MS; Division of Cardiology, University of California San Francisco, San Francisco, CA, United States.
  • Hsue PY; Division of Cardiology, University of California San Francisco, San Francisco, CA, United States.
  • Kelly JD; Department of Epidemiology and Biostatistics, University of California San Francisco, San Francisco, CA, United States.
  • Greenhouse B; Division of HIV, ID and Global Medicine, University of California San Francisco, San Francisco, CA, United States.
  • Martin JN; Department of Epidemiology and Biostatistics, University of California San Francisco, San Francisco, CA, United States.
  • Deeks SG; Division of HIV, ID and Global Medicine, University of California San Francisco, San Francisco, CA, United States.
  • Peluso MJ; Division of HIV, ID and Global Medicine, University of California San Francisco, San Francisco, CA, United States.
  • Henrich TJ; Division of Experimental Medicine, University of California San Francisco, San Francisco, CA, United States.
medRxiv ; 2023 Mar 31.
Article in En | MEDLINE | ID: mdl-37034660
Key words
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Type of study: Diagnostic_studies / Prognostic_studies / Risk_factors_studies Language: En Year: 2023 Type: Article
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Type of study: Diagnostic_studies / Prognostic_studies / Risk_factors_studies Language: En Year: 2023 Type: Article